Doctor Kathy Stein
Novartis Pharma GmbH, Nuremberg (Germany)
Different perspectives of patients and physicians on LDL-C target achievement in the treatment of hypercholesterolemia: results on secondary prevention from the German PROCYON survey
Event: ESC Congress 2021 - The Digital Experience
Topic: Secondary Prevention
Session: Risk Factors and Prevention ePosters
ESC 365 is supported by
